These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9794434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L, Petersen F, Flad HD, Brandt E.
    J Immunol; 1994 Dec 15; 153(12):5698-708. PubMed ID: 7989767
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad HD, Brandt E.
    Blood; 2000 Nov 01; 96(9):2965-72. PubMed ID: 11049972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
    Rennen HJ, Frielink C, Brandt E, Zaat SA, Boerman OC, Oyen WJ, Corstens FH.
    J Nucl Med; 2004 Jul 01; 45(7):1217-23. PubMed ID: 15235069
    [Abstract] [Full Text] [Related]

  • 7. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD, Baggiolini M, Walz A.
    Biochem J; 1991 May 01; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [Abstract] [Full Text] [Related]

  • 8. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
    Wuyts A, D'Haese A, Cremers V, Menten P, Lenaerts JP, De Loof A, Heremans H, Proost P, Van Damme J.
    J Immunol; 1999 Dec 01; 163(11):6155-63. PubMed ID: 10570306
    [Abstract] [Full Text] [Related]

  • 9. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
    Schenk BI, Petersen F, Flad HD, Brandt E.
    J Immunol; 2002 Sep 01; 169(5):2602-10. PubMed ID: 12193731
    [Abstract] [Full Text] [Related]

  • 10. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
    Ehlert JE, Petersen F, Kubbutat MH, Gerdes J, Flad HD, Brandt E.
    J Biol Chem; 1995 Mar 17; 270(11):6338-44. PubMed ID: 7890771
    [Abstract] [Full Text] [Related]

  • 11. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
    Van Damme J, Rampart M, Conings R, Decock B, Van Osselaer N, Willems J, Billiau A.
    Eur J Immunol; 1990 Sep 17; 20(9):2113-8. PubMed ID: 2145175
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects.
    Petersen F, Flad HD, Brandt E.
    J Immunol; 1994 Mar 01; 152(5):2467-78. PubMed ID: 8133058
    [Abstract] [Full Text] [Related]

  • 13. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
    Van Osselaer N, Van Damme J, Rampart M, Herman AG.
    Am J Pathol; 1991 Jan 01; 138(1):23-7. PubMed ID: 1824807
    [Abstract] [Full Text] [Related]

  • 14. A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity.
    Brandt E, Petersen F, Flad HD.
    Mol Immunol; 1993 Aug 01; 30(11):979-91. PubMed ID: 7688853
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA, Sharma A, de Nardin E.
    Cytokine; 2000 Oct 01; 12(10):1480-8. PubMed ID: 11023662
    [Abstract] [Full Text] [Related]

  • 16. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
    Qian YQ, Johanson KO, McDevitt P.
    J Mol Biol; 1999 Dec 17; 294(5):1065-72. PubMed ID: 10600366
    [Abstract] [Full Text] [Related]

  • 17. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM, Paddock DJ, LeCureux LW, Leone JW, Anderson DC, Tomasselli AG, Heinrikson RL.
    Protein Expr Purif; 1999 Jul 17; 16(2):347-54. PubMed ID: 10419831
    [Abstract] [Full Text] [Related]

  • 18. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.
    Schwartzkopff F, Brandt E, Petersen F, Flad HD, Bock L, Ludwig A.
    J Interferon Cytokine Res; 2002 Feb 17; 22(2):257-67. PubMed ID: 11911809
    [Abstract] [Full Text] [Related]

  • 19. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
    Brandt E, Petersen F, Ludwig A, Ehlert JE, Bock L, Flad HD.
    J Leukoc Biol; 2000 Apr 17; 67(4):471-8. PubMed ID: 10770278
    [Abstract] [Full Text] [Related]

  • 20. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ, Yoshimura T, Rot A, Noer K, Walz A, Baggiolini M, Walz DA, Goetzl EJ, Castor CW.
    J Leukoc Biol; 1991 Mar 17; 49(3):258-65. PubMed ID: 1997632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.